The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8).
Caspase 8
/ metabolism
Receptors, TNF-Related Apoptosis-Inducing Ligand
/ metabolism
Autophagy
Apoptosis
Caspases
/ metabolism
TNF-Related Apoptosis-Inducing Ligand
/ pharmacology
CASP8 and FADD-Like Apoptosis Regulating Protein
/ metabolism
Tumor Necrosis Factor-alpha
/ metabolism
Caspase 9
/ metabolism
FYCO1
TRAIL
apoptosis
autophagy
caspase 8
lysosomal degradation
Journal
Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
medline:
4
9
2023
pubmed:
7
7
2023
entrez:
7
7
2023
Statut:
ppublish
Résumé
Apoptosis is a tightly controlled cell death program executed by proteases, the so-called caspases. It plays an important role in tissue homeostasis and is often dysregulated in cancer. Here, we identified FYCO1, a protein that promotes microtubule plus end-directed transport of autophagic and endosomal vesicles as a molecular interaction partner of activated CASP8 (caspase 8). The absence of FYCO1 sensitized cells to basal and TNFSF10/TRAIL-induced apoptosis by receptor accumulation and stabilization of the Death Inducing Signaling Complex (DISC). Loss of FYCO1 resulted in impaired transport of TNFRSF10B/TRAIL-R2/DR5 (TNF receptor superfamily member 10b) to the lysosomes in TNFSF10/TRAIL-stimulated cells. More in detail, we show that FYCO1 interacted via its C-terminal GOLD domain with the CCZ1-MON1A complex, which is necessary for RAB7A activation and for the fusion of autophagosomal/endosomal vesicles with lysosomes. We demonstrated that FYCO1 is a novel and specific CASP8 substrate. The cleavage at aspartate 1306 resulted in the release of the C-terminal GOLD domain, inactivating FYCO1 function, and allowing for the progression of apoptosis. Furthermore, the lack of FYCO1 resulted in a stronger and prolonged formation of the TNFRSF1A/TNF-R1 signaling complex. Thus, FYCO1 limits the ligand-induced and steady-state signaling of TNFR-superfamily members, providing a control mechanism that fine-tunes both apoptotic and inflammatory answers.
Identifiants
pubmed: 37418591
doi: 10.1080/15548627.2023.2229656
pmc: PMC10472876
doi:
Substances chimiques
Caspase 8
EC 3.4.22.-
Receptors, TNF-Related Apoptosis-Inducing Ligand
0
Caspases
EC 3.4.22.-
TNF-Related Apoptosis-Inducing Ligand
0
CASP8 and FADD-Like Apoptosis Regulating Protein
0
Tumor Necrosis Factor-alpha
0
Caspase 9
EC 3.4.22.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2733-2751Références
Bioessays. 2013 Jan;35(1):34-45
pubmed: 23147242
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
Mol Cell. 2009 Dec 11;36(5):831-44
pubmed: 20005846
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Drug Resist Updat. 2015 Mar;19:13-21
pubmed: 25840763
Apoptosis. 2012 Aug;17(8):810-20
pubmed: 22644571
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):504-509
pubmed: 28049841
J Biol Chem. 2015 Dec 4;290(49):29361-74
pubmed: 26468287
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
J Biol Chem. 2008 Jul 11;283(28):19665-77
pubmed: 18375389
Cell. 2019 Jan 10;176(1-2):11-42
pubmed: 30633901
J Cell Biol. 2010 Jan 25;188(2):253-69
pubmed: 20100911
Nature. 2010 Apr 1;464(7289):778-82
pubmed: 20305638
Acta Crystallogr F Struct Biol Commun. 2017 Mar 1;73(Pt 3):130-137
pubmed: 28291748
Cancer Lett. 2009 Feb 8;274(1):95-100
pubmed: 18842334
Int J Oncol. 2015 Mar;46(3):1286-94
pubmed: 25572822
J Immunol. 1988 Nov 1;141(9):3096-100
pubmed: 2902145
Curr Biol. 2010 Sep 28;20(18):1654-9
pubmed: 20797862
Mol Biol Cell. 2016 Oct 15;27(20):3132-3142
pubmed: 27559127
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
J Biol Chem. 1988 Jul 25;263(21):10262-6
pubmed: 2839482
Autophagy. 2010 Oct;6(7):891-900
pubmed: 20724831
Breast Cancer Res Treat. 2009 Jan;113(2):217-30
pubmed: 18266105
J Biol Chem. 2018 Jan 12;293(2):731-739
pubmed: 29184002
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10283-10288
pubmed: 16801533
Autophagy. 2008 Oct;4(7):940-3
pubmed: 18769107
Mol Cell Proteomics. 2018 May;17(5):993-1009
pubmed: 29217617
J Biol Chem. 1997 Oct 24;272(43):26953-8
pubmed: 9341131
Cancer Res. 2011 May 15;71(10):3625-34
pubmed: 21444671
Cell. 2003 Jul 25;114(2):181-90
pubmed: 12887920
Cell Death Differ. 2007 Jan;14(1):66-72
pubmed: 17082814
Autophagy. 2022 Sep;18(9):2198-2215
pubmed: 35343376
J Pathol. 2010 May;221(1):3-12
pubmed: 20225336
Biochim Biophys Acta. 2013 Mar;1833(3):503-10
pubmed: 23220125
Cells. 2018 Nov 19;7(11):
pubmed: 30463228
Nat Commun. 2021 Jul 27;12(1):4569
pubmed: 34315903
Breast Cancer Res Treat. 2008 Feb;107(3):349-57
pubmed: 17453339
Aging (Albany NY). 2012 May;4(5):330-49
pubmed: 22683550
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Curr Protoc Mol Biol. 2019 Jan;125(1):e80
pubmed: 30375742
Traffic. 2013 Feb;14(2):219-32
pubmed: 23167963
Cell. 2010 Apr 30;141(3):497-508
pubmed: 20434987
Cancer Biol Ther. 2018;19(9):755-762
pubmed: 30067424
Trends Biochem Sci. 2009 Jul;34(7):319-23
pubmed: 19546006
J Invest Dermatol. 2008 May;128(5):1134-47
pubmed: 17989734
N Engl J Med. 2013 Feb 14;368(7):651-62
pubmed: 23406030
Autophagy. 2010 Nov;6(8):1042-56
pubmed: 21121091
J Cell Sci. 2009 Jul 15;122(Pt 14):2554-66
pubmed: 19549685
Cell Death Dis. 2010;1:e18
pubmed: 21364619
Science. 1998 Aug 28;281(5381):1305-8
pubmed: 9721089
Immunol Rev. 2017 May;277(1):76-89
pubmed: 28462525
Anal Chem. 2020 Mar 3;92(5):3913-3922
pubmed: 31992042
Autophagy. 2010 May;6(4):550-2
pubmed: 20364109
Front Immunol. 2021 Apr 01;12:622176
pubmed: 33868239
Cell Death Differ. 2012 Sep;19(9):1495-504
pubmed: 22441670
Cell Death Dis. 2014 Aug 28;5:e1390
pubmed: 25165876
Am J Hum Genet. 2011 Jun 10;88(6):827-838
pubmed: 21636066
Exp Cell Res. 2000 Apr 10;256(1):58-66
pubmed: 10739652
Nat Rev Cancer. 2017 May 24;17(6):352-366
pubmed: 28536452
J Biol Chem. 2007 Apr 27;282(17):12831-41
pubmed: 17327223
Autophagy. 2011 Oct;7(10):1239-41
pubmed: 21610315